Estimating the proportion of patients infected with HIV who will die of comorbid diseases.
about
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspectsEvolving clinical phenotypes in HIV-associated neurocognitive disordersHIV-associated lung infections and complications in the era of combination antiretroviral therapy.Factors associated with abnormal spirometry among HIV-infected individualsShould expectations about the rate of new antiretroviral drug development impact the timing of HIV treatment initiation and expectations about treatment benefits?Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil.One year survival of HIV-infected veterans with CD4 < 100 cells/mm3: data from a veteran cohort.Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic populationIntervention to influence behaviors linked to risk of chronic diseases: a multisite randomized controlled trial with African-American HIV-serodiscordant heterosexual couples.Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users.Cost-effectiveness of the third-agent class in treatment-naive human immunodeficiency virus-infected patients in Portugal.Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?Update on the Epidemiology and Prevention of HIV/AIDS in the United States.Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkersAverting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies.From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older AdultsPatient and provider-reported symptoms in the post-cART era.Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model.Depression symptoms and treatment among HIV infected and uninfected veterans.Critical illness in HIV-infected patients in the era of combination antiretroviral therapy.Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef.Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?Prescription long-term opioid use in HIV-infected patientsA mixed-methods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women.Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partnersHIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy?Cigarette smoking, illicit drug use, and routes of administration among heroin and cocaine usersHIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV.Definition of advanced age in HIV infection: looking for an age cut-off.The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population.Cost-effectiveness of HIV screening in patients older than 55 years of age.Estimating the impact of alcohol consumption on survival for HIV+ individualsIncorporating quality of evidence into decision analytic modeling.A framework for tailoring clinical guidelines to comorbidity at the point of careDecreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans.Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa.
P2860
Q26850063-6788F961-5352-4B92-8990-60F9D4D8F571Q26859192-5289AFD0-FED2-4128-AD62-52026ED4DA28Q27693307-D96BCDFD-B26E-46F6-9F56-D579E0A8A1F7Q28388780-EF711AF4-C877-44A1-BED8-1406CDEEC6B8Q28539995-546629D9-44E4-4B3A-9F5D-283F9E43C139Q33317290-22C94E83-59D0-4FEE-B7B4-8AA534268B68Q33634206-86F9B92B-7DC6-4883-A047-E8DEA4534F0CQ33640486-2113FD45-8E96-4F59-A460-A25EF35F6C0BQ33827836-648F8613-DB34-4C48-9D95-72013CFC93CAQ33881756-E93DFEFE-AB30-4864-AC47-F047A9BD2211Q34311573-6E2149C4-BC65-4F21-8AB1-C897F38FA873Q34427423-542ED121-20D5-4617-BE98-5234B076F61DQ34501780-ECB66CE4-D152-425B-BE03-C0EBF6570A76Q34546423-167E5A13-764E-4C6B-B0AB-2A6383F797E5Q34546597-733BE85A-23B3-4572-8214-ADB4E88C3107Q34669756-3751A117-7659-4234-A64E-0A41C8AC3412Q34802684-2BE3DCE2-30BA-4164-B7BD-BD2D20009AC7Q34994315-D356D123-F826-45E7-99DE-87087AD0D165Q35014055-923657F4-04AD-4B5D-9307-BCD7A54EA8C6Q35055102-5FAC3D6D-46A2-499A-8328-549DB6B21A55Q35070832-E0DBDF80-DADA-4E25-A994-573076D6A6D7Q35075171-05806CEA-9876-4297-9A1E-2144497D9AA5Q35095045-9D71C8D0-179C-4FBE-AD2C-3C45A1921F8FQ35095050-7B0F9B0B-7A3C-4ED2-A0BF-384C3552F485Q35185677-7A7D72F9-87F3-45FF-BC10-FB49C9CB8AFFQ35219167-B21B3E98-84C1-42D0-AAB5-444577C06376Q35641737-E737FF68-B498-4E4B-8379-DEF98F16533AQ35656717-5AD20479-F608-4415-8DC2-8D7497200217Q35694353-9BC4F4EC-269D-418A-85AA-EF3CFF5A774EQ35768120-FBD5CA5E-751A-4DC0-AAD6-88726165219FQ35840307-539C9D82-A37D-42CD-9F17-B97CBF239ADEQ36105896-9946AE67-BD6C-414D-944A-7A739AE8714AQ36177972-9A155224-D88E-456B-9D99-02C8C0E73C5CQ36187833-FDF3B7A5-BC3C-4C4D-B651-5B020F7BB19CQ36191220-F0B9F086-E1C2-4C2A-B479-76CA2D18084CQ36285942-3B313AE3-096B-4534-B9C0-F33854F22A86Q36285963-5AE05306-EB9F-4E12-8B6D-4917E08C13E1Q36285981-9C21FB53-D76E-43CC-AE77-D76289159420Q36417071-1152D6B3-195D-4A62-9337-0E5BF60CEA74Q36417372-DFFB9800-C0AD-4D8F-8C44-D8D3739FABF7
P2860
Estimating the proportion of patients infected with HIV who will die of comorbid diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Estimating the proportion of p ...... will die of comorbid diseases.
@en
type
label
Estimating the proportion of p ...... will die of comorbid diseases.
@en
prefLabel
Estimating the proportion of p ...... will die of comorbid diseases.
@en
P2093
P1476
Estimating the proportion of p ...... will die of comorbid diseases.
@en
P2093
Amy C Justice
Chung-Chou H Chang
Jennifer S Fusco
John B Wong
Mark S Roberts
R Scott Braithwaite
Stephen R Raffanti
P304
P356
10.1016/J.AMJMED.2004.12.034
P407
P577
2005-08-01T00:00:00Z